Skip to main content
SpringerLink
Log in

Quality-of-Life Impairment in Patients with Hidradenitis Suppurativa: A Canadian Study

  • Original Research Article
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Background

Hidradenitis suppurativa (HS) is a chronic relapsing condition with a clinical picture that includes solitary nodules; diffuse, painful abscesses; malodorous drainage; sinus tract formation; and scarring. Treatment options are often unsatisfactory. The adverse effects of this disease on quality of life (QoL) is not extensively studied, especially in the Canadian population.

Objectives

The objectives of this study were to (1) identify the impairment of QoL in patients with HS and the aspects that are most affected, and (2) assess the correlation between disease severity (based on Hurley’s staging) and QoL impairment.

Methods

This prospective case series studied 55 patients (38 females and 17 males) from community dermatology clinics in Ontario. All patients filled out the questionnaires for QoL data using the Dermatology Life Quality Index (DLQI) and the Short Form 36 Version 2 (SF-36v2) health survey, either in the clinic or over the telephone.

Results

The mean DLQI score was 10 ± 8.8, indicating a moderate effect on patients’ lives. In keeping with this, SF-36v2 scores were significantly reduced with respect to both physical and mental health. The severity of disease, as measured by Hurley staging, the number of lesions, and patient-reported QoL were significantly correlated with the DLQI score (β = 0.549, 0.285, 0.390, respectively; p = 0.000, 0.045, 0.004, respectively; α = 0.05).

Conclusions

The impact on QoL for patients with HS is extensive yet underestimated; quantifying and assessing the burden of disease for the individual and society will lead to establishment of funding priorities and greater awareness of this condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Wolkenstein P, Loundou A, Barrau K, Auquier P, Revuz J. Quality of Life Group of the French Society of Dermatology. Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. J Am Acad Dermatol. 2007;56(4):621–3.

    Article  PubMed  Google Scholar 

  2. Hong J, Koo B, Koo J. The psychosocial and occupational impact of chronic skin disease. Dermatol Ther. 2008;21(1):54–9.

    Article  PubMed  Google Scholar 

  3. Spear M. Hidradenitis suppurativa: a painful and debilitating condition. Plastic Surg Nursing. 2010;30(4):256–8.

    Article  Google Scholar 

  4. Kamp S, Fiehn AM, Stenderup K, Rosada C, Pakkenberg B, Kemp K, et al. Hidradenitis suppurativa: a disease of the absent sebaceous gland? Sebaceous gland number and volume are significantly reduced in uninvolved hair follicles from patients with hidradenitis suppurativa. Br J Dermatol. 2011;164(5):1017–22.

    Article  CAS  PubMed  Google Scholar 

  5. Yazdanyar S, Jemec GB. Hidradenitis suppurativa: a review of cause and treatment. Curr Opin Infect Dis. 2011;24(2):118–23.

    Article  PubMed  Google Scholar 

  6. Jemec GB. Clinical practice. Hidradenitis suppurativa. N Engl J Med. 2012;366(2):158–64.

    Article  CAS  PubMed  Google Scholar 

  7. Vazquez BG, Alikhan A, Weaver AL, Wetter DA, Davis MD. Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota. J Investig Dermatol. 2013;133(1):97–103.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Jemec GB. Hidradenitis suppurativa and immune dysregulation. Br J Dermatol. 2012;166(2):237–8.

    Article  CAS  PubMed  Google Scholar 

  9. Kromann C, Ibler KS, Kristiansen VB, Jemec GB. The influence of body weight on the prevalence and severity of hidradenitis suppurativa. Acta Derm Venereol. 2014;94(5):553-7.

  10. Ingram JR, Piguet V. Phenotypic heterogeneity in hidradenitis suppurativa (acne inversa): classification is an essential step toward personalized therapy. J Invest Dermatol. 2013;133(6):1453–6.

    Article  CAS  PubMed  Google Scholar 

  11. Scheinfeld N. Hidradenitis suppurativa: a practical review of possible medical treatments based on over 350 hidradenitis patients. Dermatol Online J. 2013;19(4):1.

    PubMed  Google Scholar 

  12. Onderdijk AJ, van der Zee HH, Esmann S, Lophaven S, Dufour DN, Jemec GB, et al. Depression in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol JEADV. 2013;27(4):473–8.

    Article  CAS  Google Scholar 

  13. Kurek A, Peters EM, Chanwangpong A, Sabat R, Sterry W, Schneider-Burrus S. Profound disturbances of sexual health in patients with acne inversa. J Am Acad Dermatol. 2012;67(3):422–8, 428.e1.

  14. Solarski ST. Living with hidradenitis suppurativa. Dermatol Nurs Dermatol Nurs Assoc. 2004;16(5):447–9.

    Google Scholar 

  15. Gold DA, Reeder VJ, Mahan MG, Hamzavi IH. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa. J Am Acad Dermatol. 2014;70(4):699–703.

    Article  PubMed  Google Scholar 

  16. Reeder VJ, Mahan MG, Hamzavi IH. Ethnicity and hidradenitis suppurativa. J Investig Dermatol. 2014;134(11):2842–3.

  17. Lewis V, Finlay AY. 10 years experience of the Dermatology Life Quality Index (DLQI). J Investig Dermatol Symp Proc. 2004;9(2):169–80.

    Article  PubMed  Google Scholar 

  18. Ware JE Jr, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care. 1995;33(4 Suppl):AS264–79.

    PubMed  Google Scholar 

  19. Ware JE Jr. SF-36 health survey update. Spine. 2000;25(24):3130–9.

    Article  PubMed  Google Scholar 

  20. Esmann S, Jemec GB. Psychosocial impact of hidradenitis suppurativa: a qualitative study. Acta Dermato Venereol. 2011;91(3):328–32.

    Article  Google Scholar 

  21. Matusiak L, Bieniek A, Szepietowski JC. Psychophysical aspects of hidradenitis suppurativa. Acta Dermato Venereol. 2010;90(3):264–8.

    Article  Google Scholar 

  22. von der Werth JM, Jemec GB. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol. 2001;144(4):809–13.

    Article  PubMed  Google Scholar 

  23. Matusiak L, Bieniek A, Szepietowski JC. Hidradenitis supprativa markedly decreases quality of life and professional activity. J Am Acad Dermatol. 2010;62(4):706–8, 708.e1.

  24. Hurley HJ. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa and familial benign pemphigus: surgical approach. In: Roenigk RK, Roeningk HH, editors. Dermatologic surgery. New York: Marcel Dekker; 1989. p. 729–39.

    Google Scholar 

  25. Section of Dermatology, Department of Dermatology and Wound Healing, School of Medicine, Cardiff University. Dermatology Life Quality Index (DLQI): frequently asked questions. Available from http://www.dermatology.org.uk/quality/dlqi/quality-dlqi-faqs.html. Accessed 2 Jun 2014.

Download references

Acknowledgments

No sources of funding were used to conduct this study or prepare this manuscript.

Afsaneh Alavi, Niloofar Anooshirvani, Whan B. Kim, Pat Coutts, and R. Gary Sibbald have no conflicts of interest that are directly relevant to the content of this study.

Author information

Authors and Affiliations

  1. Department of Medicine, University of Toronto, Toronto, ON, Canada

    Afsaneh Alavi & R. Gary Sibbald

  2. Royal College of Surgeons, Dublin, Ireland

    Niloofar Anooshirvani

  3. Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada

    Whan B. Kim

  4. Wound Healing Clinic, Mississauga, ON, Canada

    Pat Coutts & R. Gary Sibbald

  5. Women’s College Hospital (Main Building), 5th Floor, Wound Care Center, 76 Grenville Street, Toronto, ON, M5S 1B2, Canada

    Afsaneh Alavi

Authors
  1. Afsaneh Alavi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Niloofar Anooshirvani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Whan B. Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pat Coutts
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Gary Sibbald
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Afsaneh Alavi.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 455 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alavi, A., Anooshirvani, N., Kim, W.B. et al. Quality-of-Life Impairment in Patients with Hidradenitis Suppurativa: A Canadian Study. Am J Clin Dermatol 16, 61–65 (2015). https://doi.org/10.1007/s40257-014-0105-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40257-014-0105-5

Keywords

Search

Navigation